Journey Medical Corp
Related Filers (10)
- Paley Jeffrey (8)
- Maraoui Claude (6)
- De Paolantonio Ernest Robert (5)
- Smith Justin Adam (5)
- Herskowitz Neil (4)
- Toledano Miranda Jayne (4)
- Benesch Joseph (3)
- ROSENWALD LINDSAY A MD (3)
- B. Riley Financial, Inc. (2)
- Fortress Biotech, Inc. (1)
- Show More ...
Financials (10)
10-Q
Monday, 11/13/2023
Quarterly Report for period ending 2023-09-30
10-Q
Thursday, 8/10/2023
Quarterly Report for period ending 2023-06-30
10-Q
Monday, 5/22/2023
Quarterly Report for period ending 2023-03-31
NT 10-Q
Tuesday, 5/16/2023
Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2023-03-31
10-K
Friday, 3/31/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/10/2022
Quarterly Report for period ending 2022-09-30
10-Q
Tuesday, 8/9/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/10/2022
Quarterly Report for period ending 2022-03-31
10-K
Monday, 3/28/2022
Annual Report for period ending 2021-12-31
10-Q
Thursday, 12/16/2021
Quarterly Report for period ending 2021-09-30
News (23)
8-K
Tuesday, 1/2/2024
Current report filing
8-K
Friday, 12/8/2023
Current report filing
8-K
Tuesday, 11/7/2023
Current report filing
8-K
Tuesday, 9/26/2023
Current report filing
8-K
Tuesday, 9/19/2023
Current report filing
8-K
Wednesday, 9/6/2023
Current report filing
8-K
Friday, 8/18/2023
Current report filing
8-K
Tuesday, 8/8/2023
Current report filing
8-K
Wednesday, 7/26/2023
Current report filing
8-K
Friday, 6/23/2023
Current report filing
8-K
Monday, 5/22/2023
Current report filing
8-K
Wednesday, 3/29/2023
Current report filing
8-K
Friday, 1/20/2023
Current report filing
8-K
Tuesday, 1/3/2023
Current report filing
8-K
Thursday, 11/10/2022
Current report filing
8-K
Tuesday, 8/9/2022
Current report filing
8-K
Friday, 7/22/2022
Current report filing
8-K
Tuesday, 6/21/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Thursday, 3/24/2022
Current report filing
8-K
Thursday, 1/13/2022
Current report filing
8-K
Friday, 12/10/2021
Current report filing
8-K
Friday, 11/12/2021
Current report filing
Other (14)
EFFECT
Thursday, 1/26/2023
Notice of Effectiveness
CORRESP
Tuesday, 1/24/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Monday, 11/29/2021
None
CERT
Friday, 11/12/2021
Certification by an exchange approving securities for listing
8-A12B
Friday, 11/12/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Wednesday, 11/10/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 11/10/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 11/10/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 11/10/2021
Notice of Effectiveness
CORRESP
Monday, 11/8/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/22/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D/A
Tuesday, 10/5/2021
Exempt (Private) Offering
SEC STAFF LETTER
Monday, 9/27/2021
None
D
Wednesday, 9/22/2021
Exempt (Private) Offering
Ownership (41)
4
Friday, 12/8/2023
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/29/2023
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/17/2023
Smith Justin Adam: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2023
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Monday, 9/25/2023
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
Maraoui Claude: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Maraoui Claude: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Smith Justin Adam: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Toledano Miranda Jayne: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Benesch Joseph: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Thursday, 5/18/2023
Maraoui Claude: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/1/2023
De Paolantonio Ernest Robert: Statement of changes in beneficial ownership of securities
4
Thursday, 2/23/2023
Benesch Joseph: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/31/2023
Benesch Joseph: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 12/29/2022
B. Riley Financial, Inc.: Major Shareholders
4
Thursday, 10/6/2022
De Paolantonio Ernest Robert: Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 8/17/2022
Fortress Biotech, Inc.: Major Shareholders
4
Monday, 7/25/2022
Maraoui Claude: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2022
Smith Justin Adam: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2022
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2022
Toledano Miranda Jayne: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2022
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2022
De Paolantonio Ernest Robert: Statement of changes in beneficial ownership of securities
3
Monday, 7/25/2022
ROSENWALD LINDSAY A MD: Initial statement of beneficial ownership of securities
4
Monday, 7/25/2022
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
Toledano Miranda Jayne: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
De Paolantonio Ernest Robert: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
Herskowitz Neil: Statement of changes in beneficial ownership of securities
3/A
Monday, 4/4/2022
Maraoui Claude: Initial statement of beneficial ownership of securities
4
Monday, 4/4/2022
Smith Justin Adam: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
Paley Jeffrey: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/11/2022
B. Riley Financial, Inc.: Major Shareholders
3
Friday, 11/26/2021
De Paolantonio Ernest Robert: Initial statement of beneficial ownership of securities
3
Friday, 11/26/2021
Maraoui Claude: Initial statement of beneficial ownership of securities
3
Friday, 11/26/2021
Smith Justin Adam: Initial statement of beneficial ownership of securities
3
Friday, 11/26/2021
Herskowitz Neil: Initial statement of beneficial ownership of securities
3
Friday, 11/26/2021
Paley Jeffrey: Initial statement of beneficial ownership of securities
3
Friday, 11/26/2021
Toledano Miranda Jayne: Initial statement of beneficial ownership of securities
Prospectus (17)
S-8
Friday, 12/15/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Friday, 2/17/2023
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Friday, 2/17/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Friday, 12/30/2022
Registration statement for specified transactions by certain issuers
S-8
Thursday, 7/14/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 3/28/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 11/12/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-1/A
Wednesday, 11/10/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 11/10/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 11/10/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 11/8/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 10/22/2021
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Tuesday, 10/5/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Monday, 10/4/2021
Correspondence Related to Draft Registration Statement
DRSLTR
Thursday, 9/2/2021
Correspondence Related to Draft Registration Statement
DRS/A
Thursday, 9/2/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Thursday, 7/22/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (4)
DEFA14A
Friday, 4/28/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 4/28/2023
Definitive proxy statements
DEFA14A
Thursday, 4/28/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/28/2022
Definitive proxy statements